CDR2 and paraneoplastic neurologic syndrome: Mutations leading to anti-Yo overexpression were found in all tumors of women presenting with paraneoplastic neurological syndromes and detectable anti-Yo antibodies, whereas these mutations were absent in tumors of negative individuals [37].